Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Pyxis Oncology (PYXS) Other Operating Expenses (2024 - 2025)

Pyxis Oncology (PYXS) has disclosed Other Operating Expenses for 1 consecutive years, with $21.0 million as the latest value for Q4 2024.

  • On a quarterly basis, Other Operating Expenses changed N/A to $21.0 million in Q4 2024 year-over-year; TTM through Sep 2025 was $21.0 million, a N/A change, with the full-year FY2024 number at $21.4 million, down 78.08% from a year prior.
  • Other Operating Expenses was $21.0 million for Q4 2024 at Pyxis Oncology, up from $475000.0 in the prior quarter.
  • In the past five years, Other Operating Expenses ranged from a high of $21.0 million in Q4 2024 to a low of $475000.0 in Q1 2024.